Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Predictive factors of the absence of residual disease at repeated transurethral resection of the bladder. Is there a possibility to avoid it in well-selected patients?

Soria F, D'Andrea D, Moschini M, Giordano A, Mazzoli S, Pizzuto G, Hurle R, Colombo R, Briganti A, Altieri V, Shariat SF, Gontero P.

Urol Oncol. 2019 Sep 14. pii: S1078-1439(19)30328-X. doi: 10.1016/j.urolonc.2019.08.010. [Epub ahead of print]

PMID:
31526650
2.

Prostate calcifications: A case series supporting the microbial biofilm theory.

Cai T, Tessarolo F, Caola I, Piccoli F, Nollo G, Caciagli P, Mazzoli S, Palmieri A, Verze P, Malossini G, Mirone V, Bjerklund Johansen TE.

Investig Clin Urol. 2018 May;59(3):187-193. doi: 10.4111/icu.2018.59.3.187. Epub 2018 Apr 4.

3.

The Clinical Efficacy of Pollen Extract and Vitamins on Chronic Prostatitis/Chronic Pelvic Pain Syndrome Is Linked to a Decrease in the Pro-Inflammatory Cytokine Interleukin-8.

Cai T, Verze P, La Rocca R, Palmieri A, Tiscione D, Luciani LG, Mazzoli S, Mirone V, Malossini G.

World J Mens Health. 2017 Aug;35(2):120-128. doi: 10.5534/wjmh.2017.35.2.120. Epub 2017 Apr 30.

4.

The Efficacy of Umbelliferone, Arbutin, and N-Acetylcysteine to Prevent Microbial Colonization and Biofilm Development on Urinary Catheter Surface: Results from a Preliminary Study.

Cai T, Gallelli L, Meacci F, Brugnolli A, Prosperi L, Roberta S, Eccher C, Mazzoli S, Lanzafame P, Caciagli P, Malossini G, Bartoletti R.

J Pathog. 2016;2016:1590952. doi: 10.1155/2016/1590952. Epub 2016 Apr 5.

5.

Natural history of human papillomavirus infection in non-vaccinated young males: low clearance probability in high-risk genotypes.

Cai T, Perletti G, Meacci F, Magri V, Verze P, Palmieri A, Mazzoli S, Santi R, Nesi G, Mirone V, Bartoletti R.

Eur J Clin Microbiol Infect Dis. 2016 Mar;35(3):463-9. doi: 10.1007/s10096-015-2562-z. Epub 2016 Jan 11.

PMID:
26753992
6.

Asymptomatic Bacteriuria in Clinical Urological Practice: Preoperative Control of Bacteriuria and Management of Recurrent UTI.

Cai T, Mazzoli S, Lanzafame P, Caciagli P, Malossini G, Nesi G, Wagenlehner FM, Köves B, Pickard R, Grabe M, Bjerklund Johansen TE, Bartoletti R.

Pathogens. 2016 Jan 5;5(1). pii: E4. doi: 10.3390/pathogens5010004.

7.

Asymptomatic bacteriuria treatment is associated with a higher prevalence of antibiotic resistant strains in women with urinary tract infections.

Cai T, Nesi G, Mazzoli S, Meacci F, Lanzafame P, Caciagli P, Mereu L, Tateo S, Malossini G, Selli C, Bartoletti R.

Clin Infect Dis. 2015 Dec 1;61(11):1655-61. doi: 10.1093/cid/civ696. Epub 2015 Aug 12.

PMID:
26270684
8.

Chlamydia trachomatis infection is related to premature ejaculation in chronic prostatitis patients: results from a cross-sectional study.

Cai T, Pisano F, Magri V, Verze P, Mondaini N, D'Elia C, Malossini G, Mazzoli S, Perletti G, Gontero P, Mirone V, Bartoletti R.

J Sex Med. 2014 Dec;11(12):3085-92. doi: 10.1111/jsm.12699. Epub 2014 Sep 25.

PMID:
25256084
9.

Human papillomavirus infection is not related with prostatitis-related symptoms: results from a case-control study.

Bartoletti R, Cai T, Meliani E, Mondaini N, Meacci F, Addonisio P, Albanese S, Nesi G, Mazzoli S.

Int Braz J Urol. 2014 Mar-Apr;40(2):247-56. doi: 10.1590/S1677-5538.IBJU.2014.02.16.

10.

Development and validation of a nomogram predicting recurrence risk in women with symptomatic urinary tract infection.

Cai T, Mazzoli S, Migno S, Malossini G, Lanzafame P, Mereu L, Tateo S, Wagenlehner FM, Pickard RS, Bartoletti R.

Int J Urol. 2014 Sep;21(9):929-34. doi: 10.1111/iju.12453. Epub 2014 Apr 13.

11.

Coryneform bacteria in human semen: inter-assay variability in species composition detection and biofilm production ability.

Türk S, Mazzoli S, Stšepetova J, Kuznetsova J, Mändar R.

Microb Ecol Health Dis. 2014 Feb 14;25. doi: 10.3402/mehd.v25.22701. eCollection 2014.

12.

Apple consumption is related to better sexual quality of life in young women.

Cai T, Gacci M, Mattivi F, Mondaini N, Migno S, Boddi V, Gacci P, Detti B, Gontero P, Chiodini S, Mereu L, Tateo S, Mazzoli S, Malossini G, Bartoletti R.

Arch Gynecol Obstet. 2014 Jul;290(1):93-8. doi: 10.1007/s00404-014-3168-x. Epub 2014 Feb 12.

PMID:
24518938
13.

Solidago, orthosiphon, birch and cranberry extracts can decrease microbial colonization and biofilm development in indwelling urinary catheter: a microbiologic and ultrastructural pilot study.

Cai T, Caola I, Tessarolo F, Piccoli F, D'Elia C, Caciagli P, Nollo G, Malossini G, Nesi G, Mazzoli S, Bartoletti R.

World J Urol. 2014 Aug;32(4):1007-14. doi: 10.1007/s00345-013-1173-5. Epub 2013 Oct 4.

PMID:
24092275
14.

The impact of biofilm-producing bacteria on chronic bacterial prostatitis treatment: results from a longitudinal cohort study.

Bartoletti R, Cai T, Nesi G, Albanese S, Meacci F, Mazzoli S, Naber K.

World J Urol. 2014 Jun;32(3):737-42. doi: 10.1007/s00345-013-1145-9. Epub 2013 Aug 6.

PMID:
23918259
15.

Effect of human papillomavirus and Chlamydia trachomatis co-infection on sperm quality in young heterosexual men with chronic prostatitis-related symptoms.

Cai T, Wagenlehner FM, Mondaini N, D'Elia C, Meacci F, Migno S, Malossini G, Mazzoli S, Bartoletti R.

BJU Int. 2014 Feb;113(2):281-7. doi: 10.1111/bju.12244. Epub 2013 Jul 26.

16.

Rome Consensus Conference - statement; human papilloma virus diseases in males.

Lenzi A, Mirone V, Gentile V, Bartoletti R, Ficarra V, Foresta C, Mariani L, Mazzoli S, Parisi SG, Perino A, Picardo M, Zotti CM.

BMC Public Health. 2013 Feb 7;13:117. doi: 10.1186/1471-2458-13-117.

17.

Effects of pollen extract in association with vitamins (DEPROX 500®) for pain relief in patients affected by chronic prostatitis/chronic pelvic pain syndrome: results from a pilot study.

Cai T, Luciani LG, Caola I, Mondaini N, Malossini G, Lanzafame P, Mazzoli S, Bartoletti R.

Urologia. 2013 Apr 24;80 Suppl 22:5-10. doi: 10.5301/RU.2013.10597. Epub 2013 Jan 16.

PMID:
23334883
18.

Pattern of HPV infection in basal cell carcinoma and in perilesional skin biopsies from immunocompetent patients.

Zakrzewska K, Regalbuto E, Pierucci F, Arvia R, Mazzoli S, Gori A, de Giorgi V.

Virol J. 2012 Dec 17;9:309. doi: 10.1186/1743-422X-9-309.

19.

Prediction of response to bacillus Calmette-Guérin treatment in non-muscle invasive bladder cancer patients through interleukin-6 and interleukin-10 ratio.

Cai T, Nesi G, Mazzoli S, Meacci F, Tinacci G, Luciani LG, Ficarra V, Malossini G, Bartoletti R.

Exp Ther Med. 2012 Sep;4(3):459-464. Epub 2012 Jul 5.

20.

The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat?

Cai T, Mazzoli S, Mondaini N, Meacci F, Nesi G, D'Elia C, Malossini G, Boddi V, Bartoletti R.

Clin Infect Dis. 2012 Sep;55(6):771-7. doi: 10.1093/cid/cis534. Epub 2012 Jun 7.

PMID:
22677710
21.

Semen quality in patients with Chlamydia trachomatis genital infection treated concurrently with prulifloxacin and a phytotherapeutic agent.

Cai T, Wagenlehner FM, Mazzoli S, Meacci F, Mondaini N, Nesi G, Tiscione D, Malossini G, Bartoletti R.

J Androl. 2012 Jul-Aug;33(4):615-23. doi: 10.2164/jandrol.111.013961. Epub 2011 Oct 6.

PMID:
21979301
22.

Re: Eggert-Kruse et al.: Are chlamydial lipopolysaccharide-directed antibodies in seminal plasma or serum clinically significant during investigation of male infertility? (Urology 2011;77:1101-1106).

Cai T, Mazzoli S, Bartoletti R.

Urology. 2011 Sep;78(3):723; author reply 723-4. doi: 10.1016/j.urology.2011.04.071. No abstract available.

PMID:
21884923
23.

Macrolides for the treatment of chronic bacterial prostatitis: an effective application of their unique pharmacokinetic and pharmacodynamic profile (Review).

Perletti G, Skerk V, Magri V, Markotic A, Mazzoli S, Parnham MJ, Wagenlehner FM, Naber KG.

Mol Med Rep. 2011 Nov-Dec;4(6):1035-44. doi: 10.3892/mmr.2011.575. Epub 2011 Aug 25. Review.

PMID:
21874250
24.

Epidemiological features and resistance pattern in uropathogens isolated from chronic bacterial prostatitis.

Cai T, Mazzoli S, Meacci F, Boddi V, Mondaini N, Malossini G, Bartoletti R.

J Microbiol. 2011 Jun;49(3):448-54. doi: 10.1007/s12275-011-0391-z. Epub 2011 Jun 30.

PMID:
21717331
25.

Genital Chlamydia trachomatis infection is related to poor sexual quality of life in young sexually active women.

Cai T, Mondaini N, Migno S, Meacci F, Boddi V, Gontero P, Malossini G, Geppetti P, Mazzoli S, Bartoletti R.

J Sex Med. 2011 Apr;8(4):1131-7. doi: 10.1111/j.1743-6109.2010.02194.x. Epub 2011 Jan 26.

PMID:
21269400
26.

Re: May Chlamydia trachomatis be an aetiological agent of chronic prostatitis infection?. Chronic prostatitis due to Chlamydia trachomatis infection: a challenge for the urologist.

Cai T, Mazzoli S, Bartoletti R, Tiscione D, Malossini G.

Andrologia. 2011 Feb;43(1):84. doi: 10.1111/j.1439-0272.2010.01118.x. No abstract available.

PMID:
21219390
27.

Comment on: A potential role for daptomycin in enterococcal infections: what is the evidence?

Cai T, Mazzoli S, Malossini G, Bartoletti R.

J Antimicrob Chemother. 2011 May;66(5):1195-6; author reply 1196-7. doi: 10.1093/jac/dkq490. Epub 2010 Dec 23. No abstract available.

PMID:
21186192
28.

Human papillomavirus and non-muscle invasive urothelial bladder cancer: potential relationship from a pilot study.

Cai T, Mazzoli S, Meacci F, Nesi G, Geppetti P, Malossini G, Bartoletti R.

Oncol Rep. 2011 Feb;25(2):485-9. doi: 10.3892/or.2010.1083. Epub 2010 Dec 8.

PMID:
21152875
29.

Clinical and microbiological efficacy of prulifloxacin for the treatment of chronic bacterial prostatitis due to Chlamydia trachomatis infection: results from a prospective, randomized and open-label study.

Cai T, Mazzoli S, Addonisio P, Boddi V, Geppetti P, Bartoletti R.

Methods Find Exp Clin Pharmacol. 2010 Jan-Feb;32(1):39-45. doi: 10.1358/mf.2010.32.1.1423885.

PMID:
20383345
30.

Biofilms in chronic bacterial prostatitis (NIH-II) and in prostatic calcifications.

Mazzoli S.

FEMS Immunol Med Microbiol. 2010 Aug;59(3):337-44. doi: 10.1111/j.1574-695X.2010.00659.x. Epub 2010 Feb 17.

31.
32.

[Biofilm and bacterial microrganisms in genito-urinary infections].

Mazzoli S.

Infez Med. 2009 Jun;17 Suppl 1:3-9. Review. Italian.

33.

Chlamydia trachomatis infection is related to poor semen quality in young prostatitis patients.

Mazzoli S, Cai T, Addonisio P, Bechi A, Mondaini N, Bartoletti R.

Eur Urol. 2010 Apr;57(4):708-14. doi: 10.1016/j.eururo.2009.05.015. Epub 2009 May 27.

PMID:
19482415
34.

Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study.

Cai T, Mazzoli S, Bechi A, Addonisio P, Mondaini N, Pagliai RC, Bartoletti R.

Int J Antimicrob Agents. 2009 Jun;33(6):549-53. doi: 10.1016/j.ijantimicag.2008.11.012. Epub 2009 Jan 31.

PMID:
19181486
35.

A possible negative effect of co-administered amlodipine and atorvastatin on semen volume and spermatozoa in men.

Cai T, Mondaini N, Mazzoli S, Bartoletti R.

J Pharm Pharmacol. 2008 Nov;60(11):1431-2. doi: 10.1211/jpp/60.11.0002. No abstract available.

PMID:
18957162
36.

Can early single dose instillation of epirubicin improve bacillus Calmette-Guerin efficacy in patients with nonmuscle invasive high risk bladder cancer? Results from a prospective, randomized, double-blind controlled study.

Cai T, Nesi G, Tinacci G, Zini E, Mondaini N, Boddi V, Mazzoli S, Bartoletti R.

J Urol. 2008 Jul;180(1):110-5. doi: 10.1016/j.juro.2008.03.038. Epub 2008 May 15.

PMID:
18485394
37.

Re: Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.

Cai T, Mazzoli S, Bartoletti R.

J Natl Cancer Inst. 2008 Apr 16;100(8):600; author reply 600-1. doi: 10.1093/jnci/djn087. Epub 2008 Apr 8. No abstract available.

PMID:
18398096
38.

Prognostic role of cell apoptotic rate in prostate cancer: outcome of a long-time follow-up study.

Dachille G, Cai T, Ludovico GM, Vestita G, Pagliarulo G, Nesi G, Mazzoli S, Meacci F, Mondaini N, Detti B, Bartoletti R.

Oncol Rep. 2008 Feb;19(2):541-5.

PMID:
18202805
39.

Prevalence, incidence estimation, risk factors and characterization of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy: results of a multicenter case-control observational study.

Bartoletti R, Cai T, Mondaini N, Dinelli N, Pinzi N, Pavone C, Gontero P, Gavazzi A, Giubilei G, Prezioso D, Mazzoli S, Boddi V, Naber KG; Italian Prostatitis Study Group.

J Urol. 2007 Dec;178(6):2411-5; discussion 2415. Epub 2007 Oct 15.

PMID:
17937946
40.
41.

Interleukin-6/10 ratio as a prognostic marker of recurrence in patients with intermediate risk urothelial bladder carcinoma.

Cai T, Mazzoli S, Meacci F, Tinacci G, Nesi G, Zini E, Bartoletti R.

J Urol. 2007 Nov;178(5):1906-11;discussion 1911-2. Epub 2007 Sep 17.

PMID:
17868727
42.
44.

[New therapeutics in the suppression of superficial bladder carcinoma].

Bartoletti R, Cai T, Mondaini N, Farina U, Melone F, Mazzoli S.

Arch Ital Urol Androl. 2006 Dec;78(4 Suppl 1):7-8. Italian. No abstract available.

PMID:
17491548
45.

Interleukin 8 and anti-chlamydia trachomatis mucosal IgA as urogenital immunologic markers in patients with C. trachomatis prostatic infection.

Mazzoli S, Cai T, Rupealta V, Gavazzi A, Castricchi Pagliai R, Mondaini N, Bartoletti R.

Eur Urol. 2007 May;51(5):1385-93. Epub 2006 Nov 3.

PMID:
17107749
46.

Stem cell factor affects tumour progression markers in metastatic melanoma cells.

Prignano F, Gerlini G, Salvatori B, Orlando C, Mazzoli S, Pimpinelli N, Moretti S.

Clin Exp Metastasis. 2006;23(3-4):177-86. Epub 2006 Sep 22.

PMID:
17028924
47.

Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.

Cai T, Nesi G, Boddi V, Mazzoli S, Dal Canto M, Bartoletti R.

Oncol Rep. 2006 Aug;16(2):329-34.

PMID:
16820911
48.

Serum imbalance of cytokines in melanoma patients.

Moretti S, Chiarugi A, Semplici F, Salvi A, De Giorgi V, Fabbri P, Mazzoli S.

Melanoma Res. 2001 Aug;11(4):395-9.

PMID:
11479428
49.

[Chlamydia pneumoniae and myocardial infarction (CLINF). Preliminary randomized controlled study with clarithromycin. CLAINF protocol].

Vergassola R, Mazzoli S, Pazzagli L, Rabatti L, Abbate R, Taddei V, Acciai S.

Minerva Cardioangiol. 2000 Dec;48(12):411-25. Italian. No abstract available.

PMID:
11253326
50.

Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons.

Mazzoli S, Lopalco L, Salvi A, Trabattoni D, Lo Caputo S, Semplici F, Biasin M, Bl C, Cosma A, Pastori C, Meacci F, Mazzotta F, Villa ML, Siccardi AG, Clerici M.

J Infect Dis. 1999 Sep;180(3):871-5.

PMID:
10438383

Supplemental Content

Loading ...
Support Center